Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus—infected rhesus macaques: Relationship to clinical and viral status
- 1 June 1990
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 27 (6) , 666-675
- https://doi.org/10.1002/ana.410270614
Abstract
Increased concentrations of excitotoxin quinolinic acid in cerebrospinal fluid (CSF) are associated with infection with the human immunodeficiency virus (HIV-1) and have been implicated in the pathogenesis of the acquired immune deficiency syndrome (AIDS) dementia complex. In the present study, inoculation of macaques with D/1/California, an immunosuppressive serotype 1 type D retrovirus, was associated with acute and chronic increases in CSF and serum quinolinic acid concentrations in macaques that had developed SAIDS, a simian disease analogous to AIDS in humans–particularly macaques with demonstrable opportunistic infections. Kynurenic acid, an antagonist of excitatory amino acid receptors as well as the excitotoxic effects of quinolinic acid, was also increased in the CSF of SAIDS macaques, but to a significantly lesser degree than was quinolinic acid (kynurenic acid, 1.8-fold; quinolinic acid, 15.6-fold). CSF quinolinic acid, but not kynurenic acid, was also increased in viremic macaques with SAIDS-related complex (2.4-fold) and asymptomatic virus positive carriers (3.4-fold). Macaques that had recovered from D/1/California infection and were antibody positive and virus negative had normal CSF quinolinic acid and kynurenic acid concentrations. Increased activity of indoleamine-2,3-dioxygenase, the first enzyme of the kynurenine pathway, was indicated in the macaques with SAIDS by reduced serum L-tryptophan and elevated serum L-kynurenine concentrations. Macaques infected with D/1/California may provide a primate model for investigation of the mechanisms involved in increases in CSF quinolinic acid in retrovirus and other infectious diseases, including HIV-1. It remains to be determined whether the increased CSF quinolinic acid concentrations and the increased ratio of quinolinic acid to kynurenic acid have neurological significance or are a useful “marker” of infection.This publication has 58 references indexed in Scilit:
- Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndromeAnnals of Neurology, 1989
- Asymptomatic Infection of the Central Nervous System by the Macaque Immunosuppressive Type D Retrovirus, SRV-1Journal of General Virology, 1989
- Stimulation of the N-methyl-d-aspartate receptor promotes the biochemical differentiation of cerebellar granule neurons and not astrocytesBrain Research, 1989
- Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal systemNeuroscience Letters, 1989
- Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophreniaAnnals of Neurology, 1988
- 4-chloro-3-hydroxyanthranilate inhibits brain 3-hydroxyanthranate oxidaseNeurochemistry International, 1988
- Systematic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosteroneLife Sciences, 1988
- Human macrophages degrade tryptophan upon induction by interferon-gammaLife Sciences, 1987
- Monocyte function in rhesus monkeys with simian acquired immune deficiency syndromeVeterinary Immunology and Immunopathology, 1985
- Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acidNeuroscience Letters, 1984